HealthEquity (NASDAQ:HQY) was given a new $108.00 price target on by analysts at Jefferies Financial Group Inc..
HealthEquity (NASDAQ:HQY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics
HealthEquity (NASDAQ:HQY) was given a new $110.00 price target on by analysts at UBS Group AG.
HealthEquity (NASDAQ:HQY) had its price target lowered by analysts at BTIG Research from $130.00 to $110.00. They now have a "buy" rating on the stock.